NWPIF yields 183.49% · PFE yields 6.13%● Live data
📍 NWPIF pulled ahead of the other in Year 1
Combined, NWPIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NWPIF + PFE for your $10,000?
ClearStream Energy Services Inc. provides upstream, midstream, and downstream production services in Canada and the United States. The company operates through Maintenance and Construction Services, and Wear Technology Overlay Services segments. The Maintenance and Construction Services segment provides operational, maintenance, welding, fabrication, machining, construction, and turnaround services to the conventional oil and gas, oilsands, and other industries, as well as abandonment, decommissioning, and reclamation services. This segment also offers resource/labour supply services to Canadian energy companies, as well as heavy equipment operators. The Wear Technology Overlay Services segment specializes in the supply and fabrication of overlay pipe spools, pipe bends, and wear plates and vessels for corrosion and abrasion resistant applications in various end markets. The company also provides regulatory and environmental advisory services; and electrical and instrumentation services. It serves oil and gas, energy, mining, agriculture, pulp and paper, petrochemical, and water treatment industries. The company was formerly known as Tuckamore Capital Management Inc. and changed its name to ClearStream Energy Services Inc. in October 2016. ClearStream Energy Services Inc. was founded in 1967 and is headquartered in Calgary, Canada.
Full NWPIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.